Jim is a business and financial writer, who had spent almost his entire life independently reporting on different business ventures with major impact on the US and global economy. Jim places a special focus on examining IPO potentials, tech stocks, biotech stocks all while investing a great part of his early hours to researching and writing on the companies in the US markets. Jim has 10+ years of experience in financial markets.
Exact Sciences Corp (EXAS) has been a popular stock among investors in recent days due to its surging share price. On Friday, EXAS shares soared 17.3% higher as of 11…
CEI may run like COSM On December 16th 2022, COSM previously Cosmos Holdings did a 1-25 reverse split, for every 25 shares you'll receive 1. COSM also changed their name…
Why Maxar Techologies rose over 100% today On December 16th, 2022 Advent agreed to purchase Maxar Technologies for $6.4 billion which equates to purchasing all outstanding shares for $53.00 per…
There are rumors of a possible buyout of Rigel Pharmaceuticals (RIGL) stock. RIGL stock closed at $1.27 and is up $0.08 during pre-market trading. Pre-market tends to be more volatile…
Social media has become one of the most powerful tools in our modern world. It is a powerful tool for communication, marketing, and networking. In the past few years, there…